Panome Bio Inc.
Biotechnology company · Saint Louis, Missouri, United States
Panome Bio Inc. is a biotechnology company headquartered in Saint Louis, Missouri, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $881,647 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2024.
Panome Bio at a glance
What does Panome Bio do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $881,647 in total (2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $6 million sold (2024).
Frequently asked questions about Panome Bio
Where is Panome Bio headquartered?
Panome Bio Inc. is headquartered in Saint Louis, Missouri, United States.
What does Panome Bio do?
Panome Bio Inc. is a biotechnology company.
When was Panome Bio founded?
The earliest incorporation on record for Panome Bio Inc. is in 2022, according to public company registers.
Similar companies
- MediBeacon Inc.St. Louis, Missouri, United States
- C2N Diagnostics, LLCSt. Louis, Missouri, United States
- Pulse Therapeutics, Inc.St. Louis, Missouri, United States
- Cardialen, Inc.St. Louis, Missouri, United States
- Gateway Biotechnology, Inc.St. Louis, Missouri, United States
- Confluence Life Sciences, Inc.St. Louis, Missouri, United States
- BacterioScan, Inc.St. Louis, Missouri, United States
- Precision Virologics, Inc.St. Louis, Missouri, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences